Emerging Technologies & Scientific Research
PharmaVision's Emerging Technologies & Research reports provide detailed analysis of recent technological advances that may impact the discovery, development, delivery, diagnosis and treatment of disease encompassing bioinformatics, biomarkers, high throughput screening, in silico modelling, in vivo animal modelling, microfluidics, nanotechnology, systems biology and translational medicine. It also includes recent scientific advances in antisense, epigenetics, gene therapy and RNA interference and cell and tissue regeneration that may revolutionise the development of future treatments.
Emerging Technologies & Scientific Research Research Reports
Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes
Published: 14/12/2012
GBI MH 141212
Growth Strategies for Supergenerics Organizations
Published: 20/04/2012
GBIHC234MR
Nordion Inc. - Strategy and SWOT Report
Published: 28/03/2012
ML MORD 0312
Noven Pharmaceuticals, Inc
Published: 16/02/2012
DMFEB0212
ImmunoGen, Inc
Published: 31/01/2012
DM IMG 0112
BioMarin Pharmaceutical, Inc
Published: 04/11/2011
DMBIOMAR 1111
Human Genome Sciences, Inc
Published: 04/11/2011
DM HGS 1111
Celldex Therapeutics, Inc.
Published: 05/06/2011
DM CellT 0611
Global Biosimilars: Identifying 2nd generation opportunities
Published: 17/01/2011
ESP GL BIO 01/11
Cardiovascular Biomarkers
Published: 28/08/2008
ESP CV BIO 08/08
CNS Biomarkers
Published: 28/08/2008
ESP CNS BIO 08/08
Cancer Biomarkers
Published: 28/08/2008
ESP CAN BIO 08/08
